Paris Saclay Cancer Cluster (PSCC) shared a post on LinkedIn:
“Today, Campus Grand Parc becomes a meeting point for some of the scientific voices shaping the present and future of immuno-oncology.
The PSCC Summer Science Summit opens today in the Hive at Villejuif, bringing together 11 internationally recognized speakers for a full day dedicated to the latest advances in cancer immunology and immunotherapy.
A special highlight of the program: Nobel Laureate James Allison from UT MD Anderson, whose pioneering work on immune checkpoint blockade has profoundly transformed cancer treatment.
Alongside him, we are honored to welcome an outstanding line-up of speakers: Florent Ginhoux (Gustave Roussy), Matteo Iannacone (Ospedale San Raffaele), Alan Korman (Spice Bio), Max Krummel (University of California, San Francisco), Laura Mackay (The Peter Doherty Institute for Infection and Immunity), Miriam Merad, MD, PhD (Icahn School of Medicine at Mount Sinai), Shalin Naik (WEHI (Walter and Eliza Hall Institute of Medical Research)), Pa: Sharma (UT MD Anderson), Eric Vivier (CIML) and Laurence Zitvogel (Gustave Roussy).
Thank you also to our moderators: Didier Samuel (INSERM), Fabrice Barlesi (Gustave Roussy), Bruno Quesnel (Institut national du cancer), Pierre Laurent-Puig (Greater Paris University Hospitals – AP-HP), Claire Rougeulle (Institut Curie) and Eric Solary (Fondation ARC pour la recherche sur le cancer).
More than a venue, Campus Grand Parc embodies the PSCC ambition: creating a dedicated environment where world-class science, clinical expertise, entrepreneurship, industry and investment can connect to accelerate innovation in oncology.
We look forward to a day of science, exchange and shared ambition for patients.”
Other articles about PSCC on OncoDaily.